Status:
COMPLETED
Joint Outcome Study Continuation for Children With Severe Factor VIII Deficiency
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
Bayer
Rush University Medical Center
Conditions:
Hemophilia
Eligibility:
MALE
8-18 years
Brief Summary
The original Joint Outcome Study (JOS) enrolled 65 boys with hemophilia from 16 sites nationally. The subjects were randomized to one of two arms (prophylaxis or an enhanced episode-based treatment)an...
Eligibility Criteria
Inclusion
- Enrolled in the original JOS study, "A Randomized Prospective Study for the Prevention of Joint Disease in Children with Factor VIII Deficiency"
- Written, informed consent of parent or guardian for the proposed study
- The local hemophilia treatment center staff must evaluate the family's participation in the original treatment protocol and determine that the family is capable of complying with the continuation protocol
Exclusion
- Unable or unwilling to record the study information
Key Trial Info
Start Date :
November 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2017
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT01000844
Start Date
November 1 2009
End Date
October 1 2017
Last Update
October 31 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.